Chronic Lymphocytic Leukemia | Exploring Clinical Investigator Perspectives on the Optimal Management of Chronic Lymphocytic Leukemia (for Medical and Hematologic Oncologists) - a podcast by Dr Neil Love
from 2020-11-17T22:10:20
::
::
Featuring perspectives from Dr Jennifer Woyach on the following topics:
- Practical considerations in treatment of CLL for practicing clinicians — Jennifer Woyach, MD (0:00)
- Case: A man in his early 60s with CLL with an IGHV mutation and deletion 13q receives ibrutinib/obinutuzumab on the control arm of the ECOG-EA9161 trial (26:25)
- Case: A man in his mid-70s with relapsed/refractory CLL (30:45)
- Case: A woman in her late 60s initially diagnosed with CLL with deletion 17p but no IGHV mutation undergoes Richter’s transformation (32:03)
- Biomarker assessment to guide treatment selection in CLL (46:30)
- Management of treatment-naïve CLL (52:42)
- Treatment options for relapsed/refractory CLL CME information and select publications (1:25:14)
CME information and select publications
Further episodes of Research To Practice | Oncology Videos
Further podcasts by Dr Neil Love
Website of Dr Neil Love